Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Adapalene | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Adapalene | hsa00190 | Oxidative phosphorylation | 3.56E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Adapalene | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | | Adapalene | hsa00250 | Alanine, aspartate and glutamate metabolism | 1.22E-02 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | | Adapalene | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Adapalene | hsa00270 | Cysteine and methionine metabolism | 3.39E-02 | 2 | Q96RQ9, P40926 | IL4I1, MDH2 | More | | Adapalene | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Adapalene | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Adapalene | hsa00520 | Amino sugar and nucleotide sugar metabolism | 4.36E-04 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Adapalene | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | | Adapalene | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Adapalene | hsa00561 | Glycerolipid metabolism | 4.97E-04 | 5 | Q8NEB5, P51648, P14550, P23743, Q86XP1 | PPAPDC1B, ALDH3A2, AKR1A1, DGKA, DGKH | More | | Adapalene | hsa00562 | Inositol phosphate metabolism | 7.30E-04 | 4 | P27987, Q96PE3, P19174, P42338 | ITPKB, INPP4A, PLCG1, PIK3CB | More | | Adapalene | hsa00565 | Ether lipid metabolism | 3.94E-02 | 1 | Q8N661 | TMEM86B | More | | Adapalene | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Adapalene | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Adapalene | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 4.30E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Adapalene | hsa00620 | Pyruvate metabolism | 2.51E-02 | 2 | P40925, P51648 | MDH1, ALDH3A2 | More | | Adapalene | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.54E-05 | 2 | P40925, P15104 | MDH1, GLUL | More | | Adapalene | hsa00730 | Thiamine metabolism | 1.20E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Adapalene | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | | Adapalene | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Adapalene | hsa00900 | Terpenoid backbone biosynthesis | 1.22E-02 | 2 | P49354, Q9UHG3 | FNTA, PCYOX1 | More | | Adapalene | hsa00920 | Sulfur metabolism | 2.29E-02 | 1 | Q16762 | TST | More | | Adapalene | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Adapalene | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Adapalene | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Adapalene | hsa01100 | Metabolic pathways | 4.12E-02 | 12 | P15104, P51648, P42338, Q96PE3, P19174, P27987, Q13370, P40925, P23743, P43034, P09917, Q53FZ2 | GLUL, ALDH3A2, PIK3CB, INPP4A, PLCG1, ITPKB, PDE3B, MDH1, DGKA, PAFAH1B1, ALOX5, ACSM3 | More | | Adapalene | hsa01200 | Carbon metabolism | 4.06E-02 | 5 | P37837, O14521, P50213, P60891, Q02252 | TALDO1, SDHD, IDH3A, PRPS1, ALDH6A1 | More | | Adapalene | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 7.30E-04 | 4 | Q92529, P19174, P42338, Q9NRA1 | SHC3, PLCG1, PIK3CB, PDGFC | More | | Adapalene | hsa01524 | Platinum drug resistance | 1.79E-02 | 2 | O15392, P11388 | BIRC5, TOP2A | More | | Adapalene | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Adapalene | hsa03013 | RNA transport | 5.45E-03 | 10 | P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Adapalene | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Adapalene | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Adapalene | hsa03040 | Spliceosome | 2.92E-06 | 14 | Q14562, O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Adapalene | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Adapalene | hsa03320 | PPAR signaling pathway | 3.78E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | | Adapalene | hsa04012 | ErbB signaling pathway | 9.49E-03 | 3 | Q92529, P19174, P42338 | SHC3, PLCG1, PIK3CB | More | | Adapalene | hsa04014 | Ras signaling pathway | 7.65E-05 | 10 | P42338, Q92529, P20827, Q9NRA1, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, SHC3, EFNA1, PDGFC, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Adapalene | hsa04015 | Rap1 signaling pathway | 2.22E-03 | 9 | P20827, Q9NRA1, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, PDGFC, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Adapalene | hsa04020 | Calcium signaling pathway | 1.55E-03 | 9 | P27987, Q96DU7, Q13557, P21860, P19174, P26678, P63092, Q9NRA1, P49767 | ITPKB, ITPKC, CAMK2D, ERBB3, PLCG1, PLN, GNAS, PDGFC, VEGFC | More | | Adapalene | hsa04062 | Chemokine signaling pathway | 2.01E-04 | 11 | P09769, P07948, P42338, P19174, Q92529, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, SHC3, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Adapalene | hsa04064 | NF-kappa B signaling pathway | 1.09E-04 | 11 | P10415, Q13489, O00463, Q13546, Q04759, Q9UDY8, Q16548, Q13315, P24522, P09341, Q9UNE0 | BCL2, BIRC3, TRAF5, RIPK1, PRKCQ, MALT1, BCL2A1, ATM, GADD45A, CXCL1, EDAR | More | | Adapalene | hsa04070 | Phosphatidylinositol signaling system | 3.19E-04 | 5 | P19174, P42338, P23743, Q96PE3, P27987 | PLCG1, PIK3CB, DGKA, INPP4A, ITPKB | More | | Adapalene | hsa04071 | Sphingolipid signaling pathway | 8.69E-05 | 7 | P17252, P21453, Q9H228, Q13362, Q9BX95, Q16539, P10415 | PRKCA, S1PR1, EDG8, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Adapalene | hsa04072 | Phospholipase D signaling pathway | 1.85E-04 | 6 | P42338, Q92529, P19174, Q14344, P23743, Q9NRA1 | PIK3CB, SHC3, PLCG1, GNA13, DGKA, PDGFC | More | | Adapalene | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | | Adapalene | hsa04114 | Oocyte meiosis | 4.51E-03 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Adapalene | hsa04120 | Ubiquitin mediated proteolysis | 2.51E-03 | 6 | Q14145, Q13042, P62837, Q15751, O95071, P0CG47 | KEAP1, CDC16, UBE2D2, HERC1, UBR5, UBB | More | | Adapalene | hsa04122 | Sulfur relay system | 2.29E-02 | 1 | Q16762 | TST | More | | Adapalene | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Adapalene | hsa04140 | Autophagy - animal | 3.19E-02 | 4 | P22694, Q14643, P10415, Q04759 | PRKACB, ITPR1, BCL2, PRKCQ | More | | Adapalene | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Adapalene | hsa04145 | Phagosome | 1.65E-05 | 10 | O75015, Q15080, P14598, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | FCGR3B, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Adapalene | hsa04151 | PI3K-Akt signaling pathway | 7.72E-04 | 13 | P42338, P43657, P20827, Q9NRA1, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, PDGFC, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Adapalene | hsa04210 | Apoptosis | 3.44E-02 | 7 | Q13315, P10415, O76075, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ITPR1 | More | | Adapalene | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | | Adapalene | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Adapalene | hsa04217 | Necroptosis | 3.89E-06 | 13 | P01375, P01568, P48023, Q13489, Q13546, Q14765, P07900, P15104, P05141, P01584, P0C0S5, Q99878, Q13557 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT4, HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC14, CAMK2D | More | | Adapalene | hsa04270 | Vascular smooth muscle contraction | 2.89E-02 | 2 | P35579, P35318 | MYH9, ADM | More | | Adapalene | hsa04310 | Wnt signaling pathway | 1.79E-02 | 2 | P17612, P67870 | PRKACA, CSNK2B | More | | Adapalene | hsa04330 | Notch signaling pathway | 1.12E-02 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | | Adapalene | hsa04340 | Hedgehog signaling pathway | 1.92E-03 | 4 | P17612, P22694, Q13635, P10415 | PRKACA, PRKACB, PTCH1, BCL2 | More | | Adapalene | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Adapalene | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Adapalene | hsa04370 | VEGF signaling pathway | 6.63E-05 | 5 | P19174, P16298, P42338, Q05397, Q02750 | PLCG1, PPP3CB, PIK3CB, PTK2, MAP2K1 | More | | Adapalene | hsa04371 | Apelin signaling pathway | 4.48E-04 | 8 | P63218, P50151, Q8WYR1, Q13370, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, PDE3B, MEF2D, GNA13, SMAD4, SMAD3 | More | | Adapalene | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Adapalene | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Adapalene | hsa04510 | Focal adhesion | 1.55E-02 | 5 | P42338, O15335, Q9NRA1, P49767, Q92529 | PIK3CB, CHAD, PDGFC, VEGFC, SHC3 | More | | Adapalene | hsa04512 | ECM-receptor interaction | 2.00E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Adapalene | hsa04514 | Cell adhesion molecules | 3.82E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Adapalene | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Adapalene | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Adapalene | hsa04611 | Platelet activation | 4.86E-06 | 9 | Q9Y490, P08514, P42338, Q14344, Q15746, Q8WYR1, P17612, P07359, P07948 | TLN1, ITGA2B, PIK3CB, GNA13, MYLK, PIK3R5, PRKACA, GP1BA, LYN | More | | Adapalene | hsa04612 | Antigen processing and presentation | 4.48E-02 | 5 | P13765, P26715, P26717, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRD1, CD8A | More | | Adapalene | hsa04613 | Neutrophil extracellular trap formation | 6.81E-07 | 24 | P17252, P16109, O60603, P05164, P08246, Q9UM07, Q92769, Q6FI13, Q99878, Q93077, P62807, O60814, P68431, P14598, Q15080, P20160, P08311, O75015, P21730, P08514, P21462, P07359, O43315, Q16539 | PRKCA, SELP, TLR2, MPO, ELA2, PADI4, HDAC2, H2AC18; H2AC19, H2AC14, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, FCGR3B, C5AR1, ITGA2B, FPR1, GP1BA, AQP9, MAPK14 | More | | Adapalene | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Adapalene | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Adapalene | hsa04621 | NOD-like receptor signaling pathway | 4.72E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Adapalene | hsa04622 | RIG-I-like receptor signaling pathway | 5.23E-03 | 4 | P01568, Q13546, Q12933, P10145 | IFNA21, RIPK1, TRAF2, IL8 | More | | Adapalene | hsa04623 | Cytosolic DNA-sensing pathway | 2.20E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Adapalene | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Adapalene | hsa04650 | Natural killer cell mediated cytotoxicity | 2.18E-03 | 9 | P16298, P50591, O60880, P20963, Q02750, Q13241, P26718, P26717, P26715 | PPP3CB, TNFSF10, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, KLRC2, KLRC1 | More | | Adapalene | hsa04657 | IL-17 signaling pathway | 1.14E-03 | 7 | P07900, O00463, Q16539, P49841, P14780, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, MMP9, TNF, IL1B | More | | Adapalene | hsa04658 | Th1 and Th2 cell differentiation | 3.54E-05 | 11 | Q04759, P07766, P20963, P09693, P19174, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Adapalene | hsa04659 | Th17 cell differentiation | 1.02E-05 | 14 | P25963, Q04759, P19174, P14784, P13765, P14778, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | | Adapalene | hsa04660 | T cell receptor signaling pathway | 1.00E-02 | 7 | Q9UDY8, Q04759, P10747, Q08881, P20963, P09693, P01732 | MALT1, PRKCQ, CD28, ITK, CD247, CD3G, CD8A | More | | Adapalene | hsa04662 | B cell receptor signaling pathway | 1.04E-05 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Adapalene | hsa04664 | Fc epsilon RI signaling pathway | 4.92E-08 | 8 | P01375, Q16539, P42338, Q9UQC2, P07948, P19174, P09917, P20292 | TNF, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5, ALOX5AP | More | | Adapalene | hsa04666 | Fc gamma R-mediated phagocytosis | 1.56E-03 | 8 | P07948, P42338, P19174, P23528, P06396, O14494, P14598, P17252 | LYN, PIK3CB, PLCG1, CFL1, GSN, PLPP1, NCF1, PRKCA | More | | Adapalene | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Adapalene | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Adapalene | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Adapalene | hsa04713 | Circadian entrainment | 1.75E-02 | 4 | Q13557, Q02153, P61952, P63092 | CAMK2D, GUCY1B3, GNG11, GNAS | More | | Adapalene | hsa04720 | Long-term potentiation | 2.35E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Adapalene | hsa04722 | Neurotrophin signaling pathway | 3.94E-03 | 6 | P42338, P19174, Q92529, P49841, O43524, P48023 | PIK3CB, PLCG1, SHC3, GSK3B, FOXO3, FASLG | More | | Adapalene | hsa04723 | Retrograde endocannabinoid signaling | 1.75E-02 | 5 | Q14643, P17252, P22694, Q16539, Q16718 | ITPR1, PRKCA, PRKACB, MAPK14, NDUFA5 | More | | Adapalene | hsa04724 | Glutamatergic synapse | 2.62E-04 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Adapalene | hsa04725 | Cholinergic synapse | 1.84E-03 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Adapalene | hsa04726 | Serotonergic synapse | 3.41E-02 | 3 | P63218, P50151, P09917 | GNG5, GNG10, ALOX5 | More | | Adapalene | hsa04727 | GABAergic synapse | 2.70E-04 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Adapalene | hsa04728 | Dopaminergic synapse | 2.41E-02 | 5 | P63092, P61952, Q99941, Q13557, O15516 | GNAS, GNG11, CREBL1, CAMK2D, CLOCK | More | | Adapalene | hsa04730 | Long-term depression | 1.56E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Adapalene | hsa04742 | Taste transduction | 3.91E-02 | 1 | P17612 | PRKACA | More | | Adapalene | hsa04744 | Phototransduction | 2.80E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Adapalene | hsa04910 | Insulin signaling pathway | 4.11E-02 | 3 | Q92529, Q13370, P42338 | SHC3, PDE3B, PIK3CB | More | | Adapalene | hsa04911 | Insulin secretion | 4.88E-02 | 3 | P63092, Q99941, Q13557 | GNAS, CREBL1, CAMK2D | More | | Adapalene | hsa04912 | GnRH signaling pathway | 2.96E-04 | 5 | P17252, Q16539, Q9Y6R4, Q14643, P22694 | PRKCA, MAPK14, MAP3K4, ITPR1, PRKACB | More | | Adapalene | hsa04914 | Progesterone-mediated oocyte maturation | 3.89E-04 | 7 | Q17RY0, P42338, Q13370, Q9Y6D9, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, MAD1L1, HSP90AB1, RPS6KA3, MAP2K1 | More | | Adapalene | hsa04915 | Estrogen signaling pathway | 4.76E-03 | 4 | P42338, Q92529, P08238, P11142 | PIK3CB, SHC3, HSP90AB1, HSPA8 | More | | Adapalene | hsa04916 | Melanogenesis | 4.80E-02 | 4 | P0DP23, Q9UJU2, P17252, P04628 | CALM1, LEF1, PRKCA, WNT1 | More | | Adapalene | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Adapalene | hsa04921 | Oxytocin signaling pathway | 4.91E-02 | 2 | Q15746, Q8WYR1 | MYLK, PIK3R5 | More | | Adapalene | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Adapalene | hsa04923 | Regulation of lipolysis in adipocytes | 3.64E-02 | 2 | Q13370, P42338 | PDE3B, PIK3CB | More | | Adapalene | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Adapalene | hsa04926 | Relaxin signaling pathway | 2.50E-05 | 6 | P42338, P63218, P50151, P49767, Q92529, P49407 | PIK3CB, GNG5, GNG10, VEGFC, SHC3, ARRB1 | More | | Adapalene | hsa04928 | Parathyroid hormone synthesis, secretion and action | 4.10E-03 | 5 | Q14643, P22694, P23771, P17252, P10415 | ITPR1, PRKACB, GATA3, PRKCA, BCL2 | More | | Adapalene | hsa04929 | GnRH secretion | 4.62E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Adapalene | hsa04932 | Non-alcoholic fatty liver disease | 6.43E-04 | 7 | P01375, P49841, P18848, P48023, P01584, P13073, O15239 | TNF, GSK3B, ATF4, FASLG, IL1B, COX4I1, NDUFA1 | More | | Adapalene | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.54E-04 | 6 | P84022, Q13485, P10415, P42338, P49767, P19174 | SMAD3, SMAD4, BCL2, PIK3CB, VEGFC, PLCG1 | More | | Adapalene | hsa04934 | Cushing syndrome | 1.75E-02 | 4 | Q99941, P63092, O15169, Q13557 | CREBL1, GNAS, AXIN1, CAMK2D | More | | Adapalene | hsa04935 | Growth hormone synthesis, secretion and action | 2.78E-02 | 3 | P19174, P42338, Q92529 | PLCG1, PIK3CB, SHC3 | More | | Adapalene | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Adapalene | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | | Adapalene | hsa04962 | Vasopressin-regulated water reabsorption | 7.22E-03 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | | Adapalene | hsa04972 | Pancreatic secretion | 3.86E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | | Adapalene | hsa04975 | Fat digestion and absorption | 9.50E-04 | 1 | O14494 | PLPP1 | More | | Adapalene | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | | Adapalene | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Adapalene | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | | Adapalene | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.80E-02 | 6 | O15239, P13073, P18848, P05141, P01584, Q13557 | NDUFA1, COX4I1, ATF4, SLC25A5, IL1B, CAMK2D | More | | Adapalene | hsa05031 | Amphetamine addiction | 4.88E-02 | 3 | Q13557, P63092, Q99941 | CAMK2D, GNAS, CREBL1 | More | | Adapalene | hsa05032 | Morphine addiction | 2.22E-02 | 3 | P63218, P50151, Q13370 | GNG5, GNG10, PDE3B | More | | Adapalene | hsa05034 | Alcoholism | 1.96E-04 | 6 | Q96RR4, Q93077, P62807, O60814, P84243, P68431 | CAMKK2, HIST1H2AC, HIST1H2BC, H2BC12, H3F3A, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Adapalene | hsa05100 | Bacterial invasion of epithelial cells | 3.64E-02 | 2 | P42338, Q92529 | PIK3CB, SHC3 | More | | Adapalene | hsa05110 | Vibrio cholerae infection | 2.11E-03 | 2 | Q99437, P17612 | ATP6V0B, PRKACA | More | | Adapalene | hsa05132 | Salmonella infection | 2.41E-04 | 13 | P51617, P25963, Q9UJU2, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371 | IRAK1, NFKBIA, LEF1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C | More | | Adapalene | hsa05133 | Pertussis | 2.24E-02 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Adapalene | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Adapalene | hsa05135 | Yersinia infection | 2.58E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | | Adapalene | hsa05143 | African trypanosomiasis | 3.01E-03 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Adapalene | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Adapalene | hsa05150 | Staphylococcus aureus infection | 3.32E-02 | 2 | Q14532, P16109 | KRT32, SELP | More | | Adapalene | hsa05152 | Tuberculosis | 2.24E-04 | 11 | Q13488, P0DP23, O75015, P48382, O60603, P10415, P13765, P01568, Q9UDY8, Q16539, P51617 | TCIRG1, CALM1, FCGR3B, RFX5, TLR2, BCL2, HLA-DOB, IFNA21, MALT1, MAPK14, IRAK1 | More | | Adapalene | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Adapalene | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Adapalene | hsa05162 | Measles | 4.15E-03 | 6 | P14784, P07766, P42338, P11142, P01584, Q9NP90 | IL2RB, CD3E, PIK3CB, HSPA8, IL1B, RAB9B | More | | Adapalene | hsa05163 | Human cytomegalovirus infection | 1.10E-03 | 11 | P42338, P01375, P63218, P50151, Q14344, P49841, P14778, P25025, Q16539, O00463, P30101 | PIK3CB, TNF, GNG5, GNG10, GNA13, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5, PDIA3 | More | | Adapalene | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.14E-02 | 5 | P42338, P63218, P50151, P19174, P07948 | PIK3CB, GNG5, GNG10, PLCG1, LYN | More | | Adapalene | hsa05169 | Epstein-Barr virus infection | 3.61E-03 | 7 | Q13547, P42338, P07948, P30101, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, CD3E | More | | Adapalene | hsa05170 | Human immunodeficiency virus 1 infection | 2.45E-05 | 22 | P42338, Q02750, P62873, P62879, P63218, P50151, P16298, P0DP23, Q05397, P17252, O00463, P30101, Q14643, P01568, P51617, O60603, P19174, P23528, P07766, P10415, Q93034, Q9Y6Q5 | PIK3CB, MAP2K1, GNB1, GNB2, GNG5, GNG10, PPP3CB, CALM1, PTK2, PRKCA, TRAF5, PDIA3, ITPR1, IFNA21, IRAK1, TLR2, PLCG1, CFL1, CD3E, BCL2, CUL5, AP1M2 | More | | Adapalene | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Adapalene | hsa05200 | Pathways in cancer | 1.13E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Adapalene | hsa05202 | Transcriptional misregulation in cancer | 4.06E-05 | 16 | Q12778, Q15532, Q13315, P41732, P14780, P27930, P14923, Q16548, Q13489, Q13077, O15550, P35226, P05164, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, ELA2, BCL11B, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q12778 | FOXO1 | Forkhead box protein O1 | -0.769 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.794 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.795 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q15532 | SS18 | Protein SSXT | -0.803 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q15532 | SS18 | Protein SSXT | 0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P41732 | TSPAN7 | Tetraspanin-7 | 0.775 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.861 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.765 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.746 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.734 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14923 | JUP | Junction plakoglobin | 0.861 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.837 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.746 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.797 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.848 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.816 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O15550 | UTX | Lysine-specific demethylase 6A | 0.789 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O15550 | UTX | Lysine-specific demethylase 6A | -0.778 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.779 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.779 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P05164 | MPO | Myeloperoxidase | 0.805 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P05164 | MPO | Myeloperoxidase | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.846 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P08246 | ELA2 | Neutrophil elastase | -0.942 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.808 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.766 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.879 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.764 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 |
| Adapalene | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Adapalene | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Adapalene | hsa05205 | Proteoglycans in cancer | 1.09E-02 | 10 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P04628, Q13635, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, WNT1, PTCH1, CD63 | More | | Adapalene | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Adapalene | hsa05212 | Pancreatic cancer | 9.87E-04 | 5 | P42338, P37173, P84022, Q13485, O75293 | PIK3CB, TGFBR2, SMAD3, SMAD4, GADD45B | More | | Adapalene | hsa05214 | Glioma | 9.49E-03 | 3 | Q92529, P42338, P19174 | SHC3, PIK3CB, PLCG1 | More | | Adapalene | hsa05215 | Prostate cancer | 4.87E-02 | 3 | Q9NRA1, P08238, P42338 | PDGFC, HSP90AB1, PIK3CB | More | | Adapalene | hsa05218 | Melanoma | 3.64E-02 | 2 | Q9NRA1, P42338 | PDGFC, PIK3CB | More | | Adapalene | hsa05220 | Chronic myeloid leukemia | 1.44E-03 | 6 | Q13547, Q13485, P25963, P84022, P42338, O75293 | HDAC1, SMAD4, NFKBIA, SMAD3, PIK3CB, GADD45B | More | | Adapalene | hsa05222 | Small cell lung cancer | 3.77E-03 | 7 | P10826, Q13489, P10415, P25963, Q13077, O00463, P24522 | RARB, BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Adapalene | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Adapalene | hsa05231 | Choline metabolism in cancer | 1.17E-03 | 4 | P42338, Q9NRA1, P19174, P23743 | PIK3CB, PDGFC, PLCG1, DGKA | More | | Adapalene | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.84E-02 | 5 | P20963, P09693, O60603, P10747, Q04759 | CD247, CD3G, TLR2, CD28, PRKCQ | More | | Adapalene | hsa05320 | Autoimmune thyroid disease | 8.64E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Adapalene | hsa05321 | Inflammatory bowel disease | 1.66E-04 | 5 | O60603, P13765, Q14765, Q9UL17, P23771 | TLR2, HLA-DOB, STAT4, TBX21, GATA3 | More | | Adapalene | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Adapalene | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Adapalene | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Adapalene | hsa05332 | Graft-versus-host disease | 1.41E-05 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Adapalene | hsa05415 | Diabetic cardiomyopathy | 7.28E-03 | 11 | P17252, P05141, P14598, Q15080, O15239, Q16718, O14521, P13073, Q16539, Q13557, P14780 | PRKCA, SLC25A5, NCF1, NCF4, NDUFA1, NDUFA5, SDHD, COX4I1, MAPK14, CAMK2D, MMP9 | More | | Adapalene | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |